Basit öğe kaydını göster

dc.contributor.authorBulut, Sertan
dc.contributor.authorKaramanlı, Harun
dc.contributor.authorÇelik Deniz
dc.date.accessioned2023-07-28T12:36:53Z
dc.date.available2023-07-28T12:36:53Z
dc.date.issued2022en_US
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1121525/predicting-hospitalization-exacerbation-and-mortality-in-bronchiectasis-using-bronchiectasis-severity-index-and-faced-scores
dc.identifier.urihttps://hdl.handle.net/20.500.12868/2294
dc.description.abstractObjective: Bronchiectasis (BC) is a multifaceted and etiologically diverse condition and, as a result, no single endpoint can be used to determine its general severity and prognosis. Two different validated scores are currently being used to evaluate the seri ousness bronchiectasis: The bronchiectasis severity index (BSI) and the FACED score. It is aimed at comparing the bronchiectasis severity assessment questionnaires whichs are two different validated outcomes for mortality, exacerbation, and hospitalizations. Material and Methods: Medical records for 107 subjects with NCFB, for which BSI and FACED scores could be calculated, were reviewed retrospectively. The corre lations between the parameters and the BSI or FACED score were evaluated and a linear regression analysis was conducted to identify the independently associated variables of the BSI and FACED score. Results: The mean scores of FACED and BSI were 3.5±1.9 and 9.8±4.7, respectively. A statistically significant relationship was found between the FACED and BSI scores (p<0.0001), Pearson Chi-square (p=0.0001), and tau-b de Kendall (0.59; p=0.0001). It was showed a 60.7% similarity between the two scales by Kappa test (p<0.0001). BSI and FACED reported an area under ROC curve (AUC) for exacerbations of 0.758 and 0.755; and for hospitalizations (due to BE exacerbations) of 0.864 and 0.597, re spectively. The sensitivity of the BSI is higher (86% versus 59%) than the FACED rating. Conclusion: Patients tended to obtain a higher BSI score relative to the FACED score, although the correlation between the two scales was statistically significant. BSI is a helpful clinical predictor tool for identifying patients at risk of death, hos pitalization, and exacerbation in health-care systems.en_US
dc.language.isoengen_US
dc.relation.isversionof10.14744/IGH.2022.02997en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBronchiectasisen_US
dc.subjectExacerbationen_US
dc.subjectMortalityen_US
dc.subjectPredictionen_US
dc.subjectAlevlenmeen_US
dc.subjectBronşektazien_US
dc.subjectMortaliteen_US
dc.subjectTahmini Değerlendirmeen_US
dc.titlePredicting Hospitalization, Exacerbation and Mortality in Bronchiectasis Using Bronchiectasis Severity İndex and FACED Scoresen_US
dc.typearticleen_US
dc.contributor.departmentALKÜ, Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume36en_US
dc.identifier.issue2en_US
dc.identifier.startpage77en_US
dc.identifier.endpage85en_US
dc.relation.journalİzmir Göğüs Hastanesi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster